Search
for
Sort by
Research 421–450 of 1000+
- Dutasteride improves male pattern hair loss in a randomized study in identical twins
- 5-Alpha reductase deficiency
- Dutasteride: a review of current data on a novel dual inhibitor of 5alpha reductase.
- Five-alpha-reductase Inhibitors for prostate cancer prevention.
- Intracrine and Myotrophic Roles of 5α-Reductase and Androgens
- Side Effects of 5‐Alpha Reductase Inhibitors: A Comprehensive Review
- Androgens in women
- Neuroactive gonadal drugs for neuroprotection in male and female models of Parkinson's disease
- Investigation of the Plausibility of 5-Alpha-Reductase Inhibitor Syndrome
- In Vitro and In Vivo Skin Distribution of 5α-Reductase Inhibitors Loaded Into Liquid Crystalline Nanoparticles
- Adverse Effects and Safety of 5-alpha Reductase Inhibitors (Finasteride, Dutasteride): A Systematic Review.
- Long-term safety and efficacy of dutasteride in the treatment of male patients with androgenetic alopecia
- Dutasteride reduces alcohol’s sedative effects in men in a human laboratory setting and reduces drinking in the natural environment
- The effectiveness of finasteride and dutasteride used for 3 years in women with androgenetic alopecia
- Male Breast Cancer and 5α-Reductase Inhibitors Finasteride and Dutasteride
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Neurosteroids Are Endogenous Neuroprotectants in an Ex Vivo Glaucoma Model
- The Effect of 5 -Reductase Inhibitors on Erectile Function
- Contemporary medical therapy for polycystic ovary syndrome
- Post-finasteride syndrome: a surmountable challenge for clinicians
- Gas chromatography/mass spectrometry based hair steroid profiling may reveal pathogenesis in hair follicles of the scalp
- Differential expression of steroid 5α-reductase isozymes and association with disease severity and angiogenic genes predict their biological role in prostate cancer
- Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort study
- 5α-Reductase inhibitors in androgenetic alopecia
- Key targets of hormonal treatment of prostate cancer. Part 2: the androgen receptor and 5α-reductase
- The 5α-reductase inhibitor Dutasteride but not Finasteride protects dopamine neurons in the MPTP mouse model of Parkinson’s disease
- Dutasteride nanocapsules for hair follicle targeting: Effect of chitosan-coating and physical stimulus
- 5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interaction
- Frontal fibrosing alopecia: Regrowth following cessation of sunscreen on the forehead
- Pharmacogenetic analysis of human steroid 5α reductase type II: comparison of finasteride and dutasteride